Timeline milestone
Monoclonal Antibodies Make Molecular Targeting Possible
From How Cancer Treatment Became Personal: From Chemotherapy to Precision Immunotherapy
-
Discovery
Monoclonal Antibodies Make Molecular Targeting Possible
A method for producing identical antibodies created a platform that could recognize one molecular target with far greater specificity than conventional chemotherapy.
The hybridoma technique did not immediately deliver a cancer drug. It provided the manufacturing foundation for antibodies that could bind proteins on tumour cells or alter immune signalling. Turning the platform into safe, durable medicines required another two decades of engineering.
Sources & references 1 source
